Skip to Main Content
Santa Monica, CA and Houston, TX –
January 4, 2022

Symplr to Acquire Midas Health Analytics Solutions from Conduent

Acquisition of Midas software solutions rooted in improving clinical and financial outcomes for hospitals and health systems

symplr®, a global leader in enterprise healthcare operations including governance, risk management, and compliance (“GRC”) SaaS solutions, backed by Clearlake Capital Group, L.P. (together with its affiliates, “Clearlake”) and Charlesbank Capital Partners (together with its affiliates, “Charlesbank”), announced today that it has agreed to acquire Midas Health Analytics Solutions (“Midas”) from Conduent Incorporated (Nasdaq: CNDT) (“Conduent”). The transaction is expected to close in the first quarter of 2022, subject to the satisfaction of customary closing conditions and regulatory approvals.

“Midas Health Analytics Solutions brings actionable data and insights to help symplr’s health system clients improve patient care and deliver better outcomes,” said BJ Schaknowski, CEO of symplr. “With integrated quality outcomes and machine learning-based advanced analytics, our combined compliance, quality and safety software portfolio can better predict patient specific risks, deliver population health insights, and proactively improve and support business intelligence performance further advancing symplr’s mission of transforming healthcare operations.”

Midas Health Analytics Solutions leverage a robust data warehouse with over 100 million claims and 30,000+ indicators as well as comparative data from approximately 800 hospitals. Through its clinical and analytics transformation software solutions, Midas offers strategic guidance, tactical plans, and care management interventions to help healthcare customers improve health outcomes for patients.

“As part of our strategy to streamline our portfolio, we consider divestitures of select businesses in order to enhance shareholder and client value.” said Cliff Skelton, Conduent President and CEO. “We believe this is a mutually beneficial transaction and we are focused on providing a seamless transition for our clients. We are committed to delivering robust business process solutions to all industries, including the healthcare industry.”

For more than 30 years, symplr has been committed to improving healthcare operations through its SaaS based solutions, driving better operations for better outcomes. Historically, healthcare operations have been addressed in silos, with different people and point solutions managing staff, data, contracts, compliance, quality, and a myriad of other mission-critical components. Significant efficiencies, valuable insights, and improved outcomes are attainable by integrating these functions to ensure that overarching business strategies are data-driven and consistent across the organization.

“The Midas acquisition further strengthens symplr’s comprehensive healthcare operations SaaS solutions that enable hospitals and health systems to efficiently navigate the complexities of integrating critical business operations,” said Behdad Eghbali, Co-Founder and Managing Partner of Clearlake. “We look forward to supporting the company as it continues driving industry consolidation and accelerating organic growth through our O.P.S. value creation framework.”

Ryan Carroll, Managing Director of Charlesbank, added, “symplr is committed to delivering the industry’s deepest healthcare operations and GRC software portfolio. The acquisition of the Midas suite of solutions will extend symplr’s comprehensive quality and safety offering, helping health systems to improve operations and patient safety.”

Sidley Austin LLP provided legal counsel for symplr and Holland & Knight LLP provided legal counsel for Conduent.